Joscilin Mathew1, Nils Patrick Nickel2. 1. Department of Internal Medicine, Texas Tech University Health Science Center, 4800 Alberta Ave, El Paso, TX, 79905, USA. 2. Department of Internal Medicine, Texas Tech University Health Science Center, 4800 Alberta Ave, El Paso, TX, 79905, USA. Np.nickel@ttuhsc.edu.
Abstract
PURPOSE OF REVIEW: This review is intended to give an overview of the epidemiology of cardiovascular morbidity and mortality in patients with impaired lung function with an emphasis on patients with COPD. RECENT FINDINGS: Despite shared risk factors, lung disease is an emerging independent risk factor for cardiovascular disease and cardio-vascular disease (CVD) outcomes. Both CVD and chronic lung disease contribute significantly to overall mortality. Especially patients with chronic obstructive pulmonary disease (COPD) are at high risk for CVD-related mortality. In patients with chronic lung disease, a low index of suspicion should be maintained to assess for CVD and vice versa. Early detection of chronic lung disease as a potentially modifiable CVD risk factor could have important impact on patient outcomes.
PURPOSE OF REVIEW: This review is intended to give an overview of the epidemiology of cardiovascular morbidity and mortality in patients with impaired lung function with an emphasis on patients with COPD. RECENT FINDINGS: Despite shared risk factors, lung disease is an emerging independent risk factor for cardiovascular disease and cardio-vascular disease (CVD) outcomes. Both CVD and chronic lung disease contribute significantly to overall mortality. Especially patients with chronic obstructive pulmonary disease (COPD) are at high risk for CVD-related mortality. In patients with chronic lung disease, a low index of suspicion should be maintained to assess for CVD and vice versa. Early detection of chronic lung disease as a potentially modifiable CVD risk factor could have important impact on patient outcomes.
Authors: Suellen M Curkendall; Cynthia DeLuise; Judith K Jones; Stephan Lanes; Mary Rose Stang; Earl Goehring; Dewei She Journal: Ann Epidemiol Date: 2005-07-21 Impact factor: 3.797
Authors: Emily B Schroeder; Verna Lamar Welch; David Couper; F Javier Nieto; Duanping Liao; Wayne D Rosamond; Gerardo Heiss Journal: Am J Epidemiol Date: 2003-12-15 Impact factor: 4.897
Authors: Richard B Hubbard; Chris Smith; Ivan Le Jeune; Jonathan Gribbin; Andrew W Fogarty Journal: Am J Respir Crit Care Med Date: 2008-08-28 Impact factor: 21.405
Authors: Odilson M Silvestre; Wilson Nadruz; Gabriela Querejeta Roca; Brian Claggett; Scott D Solomon; Maria C Mirabelli; Stephanie J London; Laura R Loehr; Amil M Shah Journal: J Am Coll Cardiol Date: 2018-09-04 Impact factor: 24.094